Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Ajit K. Paul"'
Autor:
Mohammad Saifuddin, Ajit K. Paul, Sultana M. Shefin, Md. Jahangir Alam, Shahjada Selim, Sunjida Islam, Tanjina Hossain, Sadiqa Tuqan, Nusrat Sultana, Marufa Mustari, Ramen C. Basak, Kazi A. Aftab, Indrajit Prasad, Mohammad R. Uddin, Shoma Sharker, Md. Abu Jar Gaffar, Mohammad M. Rahman, Mohammad A. Hannan, Afsar Ahammed, ABM Kamrul-Hasan
Publikováno v:
Indian Journal of Endocrinology and Metabolism, Vol 28, Iss 5, Pp 500-509 (2024)
Background: Empagliflozin is a relatively newer glucose-lowering drug (GLD) with many extra-glycemic benefits. To date, no study has evaluated the efficacy and safety of empagliflozin in Bangladeshi patients with type 2 diabetes mellitus (T2DM). Obje
Externí odkaz:
https://doaj.org/article/70e8fbdd22054143beaad373bede1e9c
Publikováno v:
Journal of Family Medicine and Primary Care, Vol 9, Iss 7, Pp 3444-3449 (2020)
Background: Both obesity and vitamin D deficiency are pandemics and both have influences on cardiovascular parameters. The reported prevalence of vitamin D deficiency in obesity is high. Data relating to vitamin D status in obese is currently lacking
Externí odkaz:
https://doaj.org/article/164c48a6f6ba499f914e0cdb23255744
Autor:
Ajit K Paul, A. B.M. Kamrul-Hasan
Publikováno v:
Journal of Diabetology, Vol 11, Iss 3, Pp 163-168 (2020)
Background: Hypoglycemia is almost inevitable complication of diabetes treatment and the most important barrier in achieving tight glycemic control in diabetes patients. Objective: To describe characteristics of the patients with T2DM presenting with
Externí odkaz:
https://doaj.org/article/6bcdd3003743478bbdaf6f4336953340
Autor:
A. B. M. Kamrul-Hasan, Ajit K Paul
Publikováno v:
Journal of Diabetology, Vol 11, Iss 3, Pp 163-168 (2020)
Background: Hypoglycemia is almost inevitable complication of diabetes treatment and the most important barrier in achieving tight glycemic control in diabetes patients. Objective: To describe characteristics of the patients with T2DM presenting with